Lumida
/OFIX
⌘K
Orthofix Medical Inc

Orthofix Medical Inc

OFIX
$11.58USD↓-2.61%-0.31 today

MARKET CAP

468.1M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$11 – $12

52W RANGE

$9
$17

AI Summary

Stalk
TrimMedium

The asset remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. Price has been rejected at the 9/20 EMA band repeatedly, reinforcing a medium-term bearish bias. Oversold status does not grant mean-reversion permission, and short-term timing is neutral. Execution should be deferred into future rally attempts into EMA resistance rather than sold immediately. A Trim is recommended to seek a better entry point on a bounce into the EMAs.

  • ↑Virada spinal system launch expected to enhance surgical efficiency and penetrate $2B US pedicle screw market.
  • ↑Q1 net sales $196.4M, up 3% YoY; top 30 distributors drove 27% growth.
  • ↓Medicare reimbursement reversals and FDA reclassification risk could shrink revenue.
Full analysis →
Insider Trades45 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Jun 18, 2026SellOFIXAviva McpherronPres, Global Ops & Qual3,670$9.38$468.1M-31.84%+30.85%$34.4K-5.24%—Trim
Apr 16, 2026SellOFIXJorge Andres CedronCLO3,743$12.82$468.1M-31.84%+30.85%$48.0K-5.97%—Trim
Mar 17, 2026SellOFIXLucas VitaleCP&BOO4,269$11.92$468.1M-31.84%+30.85%$50.9K-2.59%—Trim
Mar 4, 2026SellOFIXPatrick FisherPresident, Global Limb Recon1,536$12.74$468.1M-31.84%+30.85%$19.6K-1.48%—Trim
Mar 4, 2026SellOFIXMax ReinhardtPresident, Global Spine2,133$12.74$468.1M-31.84%+30.85%$27.2K-3.96%—Trim
Mar 4, 2026SellOFIXLucas VitaleCP&BOO2,312$12.74$468.1M-31.84%+30.85%$29.4K-0.69%—Trim
Mar 4, 2026SellOFIXAviva McpherronPres, Global Ops & Qual2,559$12.74$468.1M-31.84%+30.85%$32.6K-1.83%—Trim
Mar 4, 2026SellOFIXJorge Andres CedronCLO2,775$12.74$468.1M-31.84%+30.85%$35.3K-2.14%—Trim
Mar 4, 2026SellOFIXJulie AndrewsCFO4,788$12.74$468.1M-31.84%+30.85%$61.0K-2.59%—Trim
Mar 4, 2026SellOFIXMassimo CalafiorePresident & CEO12,220$12.74$468.1M-31.84%+30.85%$155.6K-1.86%—Trim
Jan 16, 2026SellOFIXJulie AndrewsCFO4,873$14.38$468.1M-31.84%+30.85%$70.1K-7.75%—Trim
Jan 9, 2026SellOFIXMassimo CalafiorePresident & CEO19,397$15.52$468.1M-31.84%+30.85%$301.0K-4.18%—Trim
Aug 18, 2025SellOFIXPatrick FisherPresident, Global Orthopedics1,996$14.21$468.1M-31.84%+30.85%$28.4K-6.22%—Trim
Jun 18, 2025SellOFIXAviva McpherronPres, Global Ops & Qual3,728$10.51$468.1M-31.84%+30.85%$39.2K-7.45%—Trim
Jun 11, 2025SellOFIXMax ReinhardtPresident, Global Spine1,643$11.64$468.1M-31.84%+30.85%$19.1K-5.64%—Trim
May 9, 2025BuyOFIXMassimo CalafiorePresident & CEO10,000$12.54$468.1M-31.84%+30.85%$125.4K+4.45%—Trim
Apr 16, 2025SellOFIXJorge Andres CedronCLO3,816$13.31$468.1M-31.84%+30.85%$50.8K-8.24%—Trim
Apr 2, 2025SellOFIXGeoffrey C GillespieCAO76$15.74$468.1M-31.84%+30.85%$1.2K-0.18%—Trim
Mar 18, 2025SellOFIXGeoffrey C GillespieCAO296$16.60$468.1M-31.84%+30.85%$4.9K-0.69%—Trim
Mar 18, 2025SellOFIXLucas VitaleCP&BOO4,287$16.60$468.1M-31.84%+30.85%$71.2K-3.07%—Trim
Mar 5, 2025BuyOFIXMassimo CalafiorePresident & CEO9,914$17.43$468.1M-31.84%+30.85%$172.8K+4.67%—Trim
Feb 3, 2025SellOFIXGeoffrey C GillespieCAO954$17.85$468.1M-31.84%+30.85%$17.0K-1.20%—Trim
Jan 16, 2025SellOFIXJulie AndrewsCFO4,655$17.89$468.1M-31.84%+30.85%$83.3K-14.12%—Trim
Jan 10, 2025SellOFIXGeoffrey C GillespieCAO475$16.98$468.1M-31.84%+30.85%$8.1K-0.59%—Trim
Jan 10, 2025SellOFIXMassimo CalafiorePresident & CEO19,281$16.98$468.1M-31.84%+30.85%$327.4K-6.97%—Trim
Jan 7, 2025SellOFIXGeoffrey C GillespieCAO476$17.05$468.1M-31.84%+30.85%$8.1K-0.58%—Trim
Dec 17, 2024SellOFIXGeoffrey C GillespieCAO26$17.84$468.1M-31.84%+30.85%$463.84-0.06%—Trim
Aug 15, 2024BuyOFIXPatrick FisherPresident, Global Orthopedics15,319$16.32$468.1M-31.84%+30.85%$250.0K+43.53%—Trim
Jun 10, 2024BuyOFIXMax ReinhardtPresident, Global Spine14,401$13.02$468.1M-31.84%+30.85%$187.5K+7.55%—Trim
Jun 8, 2024SellOFIXKimberley A. EltingPresident, Global Orthopedics4,267$13.42$468.1M-31.84%+30.85%$57.3K-1.84%—Trim
Apr 15, 2024BuyOFIXJorge Andres CedronCLO28,648$13.09$468.1M-31.84%+30.85%$375.0K+44.20%—Trim
Apr 11, 2024SellOFIXKimberley A. EltingPresident, Global Orthopedics2,938$13.95$468.1M-31.84%+30.85%$41.0K-1.25%—Trim
Apr 1, 2024SellOFIXGeoffrey C GillespieCAO70$14.06$468.1M-31.84%+30.85%$984.2-0.17%—Trim
Apr 1, 2024SellOFIXKimberley A. EltingPresident, Global Orthopedics2,031$14.06$468.1M-31.84%+30.85%$28.6K-0.86%—Trim
Mar 15, 2024BuyOFIXGeoffrey C GillespieCAO3,639$13.74$468.1M-31.84%+30.85%$50.0K+7.98%—Trim
Feb 1, 2024SellOFIXKimberley A. EltingPresident, Global Orthopedics2,015$14.27$468.1M-31.84%+30.85%$28.8K-0.84%—Trim
Jan 15, 2024BuyOFIXJulie AndrewsCFO32,967$13.65$468.1M-31.84%+30.85%$450.0K+42.88%—Trim
Jan 8, 2024SellOFIXKevin J. KennyPresident of Global Spine1,511$13.29$468.1M-31.84%+30.85%$20.1K-1.03%—Trim
Jan 8, 2024BuyOFIXMassimo CalafiorePresident & CEO141,084$13.29$468.1M-31.84%+30.85%$1.9M+35.99%—Trim
Jan 5, 2024SellOFIXKevin J. KennyPresident of Global Spine2,955$12.67$468.1M-31.84%+30.85%$37.4K-2.05%—Trim
Jan 5, 2024BuyOFIXGeoffrey C GillespieVP, Controller, Interim CFO5,162$13.23$468.1M-31.84%+30.85%$68.3K+5.53%—Trim
Jan 5, 2024BuyOFIXKimberley A. EltingPresident, Global Orthopedics24,039$13.16$468.1M-31.84%+30.85%$316.2K+2.78%—Trim
Jan 3, 2024SellOFIXKimberley A. EltingPresident, Global Orthopedics1,778$12.96$468.1M-31.84%+30.85%$23.0K-0.78%—Trim
Dec 15, 2023SellOFIXGeoffrey C GillespieVP, Controller, Interim CFO24$12.12$468.1M-31.84%+30.85%$290.88-0.07%—Trim
Dec 4, 2023SellOFIXKevin J. KennyPresident of Global Spine609$10.79$468.1M-31.84%+30.85%$6.6K-0.42%—Trim